CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.

Yichong NingChunqing WangXin LiuYan DuShunlian LiuKaili LiuJianlin ZhouChang Zhou

Published in: Journal of experimental & clinical cancer research : CR (2019)

This study revealed a CK2/CCDC106/p53 signaling axis in the progression of breast and cervical cancers, which may provide a new therapeutic target for cancer treatment.

Keyphrases

protein kinase
papillary thyroid
squamous cell
single cell
childhood cancer